Getting ready for a strategic: a toolkit for medtech startups
Strategics can become partners, investors or acquirers. Learn what they look for and how your medtech startup can prepare, from regulatory strategy to IP.
-
-
Scrappy is not the same as cheap
Every dollar you spend is a trade-off. A dollar spent on one thing is a dollar that is not available for the next. Some of that money costs ownership. When it does, overspending means founders and early investors give up a bigger share of what they built through dilution. That is why the instinct to…
-
The scorecard investors already run on your commercialization plan
Most founders assume a pitch lives or dies on the technology. The panelists on this year’s Designing for Commercialization session at Houston MedTech Oktoberfest made a different case: by the time a team is in the room, investors have usually already decided the science is credible. What they’re actually evaluating is everything sitting quietly around…
-
When the company outgrows the team running it
We recently held a webinar with Nirav Sheth, Executive and Team Performance Coach and Founder of Stratosphere, LLC., focusing on what happens when leadership teams stall, and what CEOs can do about it. Here are some takeaways. Click here to watch the full webinar. Ask a medtech leadership team what the number one priority is and ask each person…
-
Medtech advantage is built together
Reflections from Bernstein Private Wealth Management’s Medical Devices Study Group We spend a lot of time with teams who are building the future of medtech. They are solving real problems, making high-stakes decisions and trying to create momentum with limited time and resources. That work can feel lonely at times. It doesn’t have to be….
-
10 MORE mistakes medtech startups make — and how to avoid them
In our previous article, we explored ten common mistakes medtech startups make while developing and commercializing a medical device. This article continues that conversation with mistakes 11 through 20—additional challenges that can create avoidable delays, costs and barriers to adoption. Bringing a medical device to market requires much more than a strong product and a clear clinical need….
-
FDA clearance is taking longer: How smart medtech startups are adapting
FDA timelines are getting longer. That changes how medtech startups should build. For medtech founders, FDA clearance has always mattered. But the latest reporting on device review timelines reinforces something we are feeling across the industry: getting to market is taking longer, even as approvals continue to rise. That matters because regulatory timing is no longer just a compliance issue — it is a business…
-
10 Mistakes medtech startups make — and how to avoid them
Bringing a medical device to market is never just a product challenge. It is a market challenge, a regulatory challenge, a reimbursement challenge, a workflow challenge and ultimately a credibility challenge. Startups that understand this early tend to move faster, waste less capital and build stronger businesses. Startups that do not often find themselves solving…
-
FDA Pathways, Simplified
If you are building a medtech company, one of the first big questions you may have is: what FDA pathway applies to my medical device? The applicable regulatory pathway may affect your timeline, evidence plan, budget and go-to-market strategy, so understanding it early can save real time and money. The good news is that most…
-
Winner of 2026 Avio Medtech MVP Pitch Contest Announced
Congratulations to LIQID Medical, who was named the winner of the 2026 Avio Medtech MVP Pitch Contest at the Medtech MVP Venture & Partnering Conference in Minneapolis, MN. The company earned the $19,000 non-dilutive cash prize after presenting its novel approach to glaucoma treatment. LIQID Medical is developing novel ocular implants for glaucoma treatment, including…
